| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:51637632:2491 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:51637632:2491?format=raw |
LEADER: 02491cam a2200301 a 4500
001 4048876
005 20221027024407.0
008 950828s1995 dcua b 000 0 eng d
010 $a 94069722
020 $a0309052289
035 $a(OCoLC)ocm33054260
035 $9AKV4415HS
035 $a(NNC)4048876
035 $a4048876
040 $aMMU$cMMU$dOrLoB
245 00 $aBiologic markers in urinary toxicology /$cSubcommittee on Biologic Markers in Urinary Toxicology, Committee on Biologic Markers [and others].
260 $aWashington, D.C. :$bNational Academy Press,$c1995.
300 $axii, 309 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references (p. 227-309).
505 00 $g1.$tIntroduction.$tBiologic Markers.$tValidity of Biologic Markers.$tEthical Issues.$tStructure of the Report --$g2.$tToxic Exposure of the Urinary Tract.$tThe Urinary Tract.$tMechanisms of Renal Toxicity.$tHost Factors in Renal Toxicity.$tClinical Effects of Chemical Exposure on the Kidney.$tCancer of the Bladder, Kidney, and Prostate.$tAnimal Models of Interstitial Cystitis --$g3.$tBiologic Markers of Susceptibility and Exposure.$tPopulations at Risk.$tMarkers of Susceptibility.$tMarkers of Exposure --$g4.$tBiologic Markers of Effect.$tExternal Visualization.$tUrinary Clearance Measurements.$tUrinalysis.$tMarkers of Cytotoxicity and Cellular Response.$tMarkers of Neoplasia.$tMarkers of Interstitial Cystitis --$g5.$tBiologic Markers in Extrapolation.$tBasis of Extrapolation.$tTechniques Used in Risk Assessment.$tImproved Risk-Assessment Extrapolation --$g6.$tNew Technologies.$tMarkers of Cell Injury, Regeneration, and Hypertrophy.$tCancer of the Bladder.$tDifferential-Display Polymerase Chain Reaction.
505 80 $tCancer of the Prostate.$tCancer of the Kidney.$g7.$tConclusions and Recommendations.$tToxic Exposure of the Urinary Tract.$tBiologic Markers of Exposure and Susceptibility.$tBiologic Markers of Effect.$tUse of Biologic Markers in Extrapolation.$tNew Technologies.
650 12 $aUrogenital Diseases$xprevention & control.
650 22 $aBiomarkers$xurine.$0https://id.nlm.nih.gov/mesh/D015415Q000652
650 22 $aXenobiotics$xtoxicity.$0https://id.nlm.nih.gov/mesh/D015262Q000633
710 2 $aNational Research Council (U.S.).$bSubcommittee on Biologic Markers in Urinary Toxicology.$0http://id.loc.gov/authorities/names/n96034083
852 00 $boff,hsl$hRA918.N45$iB56 1995